Clinical trial
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage…
NCT00014118 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00014118 |
|---|---|
| Title | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer |
| Official title | A Phase II Trial OF Chemoradiation For Organ Preservation In Resectable Stage III or IV Squamous Cell Carcinomas Of The Larynx Or Oropharynx |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, paclitaxel, conventional surgery, radiation therapy |
| Start date | Jun 6, 2001 |
| Primary completion | Mar 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: